The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: from bench to bedside

被引:136
作者
Boland, C. Richard [1 ,2 ]
Koi, Minoru [1 ,2 ]
Chang, Dong K. [3 ]
Carethers, John M. [4 ]
机构
[1] Baylor Univ, Med Ctr, Dept Internal Med, Dallas, TX 75246 USA
[2] Baylor Univ, Med Ctr, Sammons Canc Ctr, Dallas, TX 75246 USA
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[4] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
关键词
Lynch syndrome; HNPCC; DNA mismatch repair; microsatellite instability; MSH2; MLH1; MSH6; PMS2; colorectal cancer; familial cancer;
D O I
10.1007/s10689-007-9145-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lynch syndrome is an inherited disease caused by a germline mutation in one of four DNA mismatch repair (MMR) genes. The clinical manifestations can be somewhat variable depending upon which gene is involved, and where the mutation occurs. Moreover, the approach to the diagnosis of Lynch syndrome is becoming more complex as more is learned about the disease, and one needs to understand how the DNA MMR proteins function, and what makes them malfunction, to have an optimal appreciation of how to interpret diagnostic studies such as microsatellite instability and immunohistochemistry of the DNA MMR proteins. Finally, an understanding of the role of the DNA MMR system in regulation of the cell cycle and the response to DNA damage helps illuminate the differences in natural history and response to chemotherapeutic agents seen in Lynch syndrome.
引用
收藏
页码:41 / 52
页数:12
相关论文
共 44 条
  • [1] hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6
    Acharya, S
    Wilson, T
    Gradia, S
    Kane, MF
    Guerrette, S
    Marsischky, GT
    Kolodner, R
    Fishel, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) : 13629 - 13634
  • [2] Aebi S, 1996, CANCER RES, V56, P3087
  • [3] Frequent somatic mutations of hMSH3 with reference to microsatellite instability in hereditary nonpolyposis colorectal cancers
    Akiyama, Y
    Tsubouchi, N
    Yuasa, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) : 248 - 252
  • [4] Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines
    Arnold, CN
    Goel, A
    Boland, CR
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (01) : 66 - 73
  • [5] Microsatellite instability and colorectal cancer prognosis
    Benatti, P
    Gafà, R
    Barana, D
    Marino, M
    Scarselli, A
    Pedroni, M
    Maestri, I
    Guerzoni, L
    Roncucci, L
    Menigatti, M
    Roncari, B
    Maffei, S
    Rossi, G
    Ponti, G
    Santini, A
    Losi, L
    Di Gregorio, C
    Oliani, C
    de Leon, MP
    Lanza, G
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (23) : 8332 - 8340
  • [6] Lynch syndrome: Form, function, proteins, and basketball
    Boland, CR
    Fishel, R
    [J]. GASTROENTEROLOGY, 2005, 129 (02) : 751 - 755
  • [7] Boland CR, 1998, CANCER RES, V58, P5248
  • [8] Mismatch repair proficiency and in vitro response to 5-fluorouracil
    Carethers, JM
    Chauhan, DP
    Fink, D
    Nebel, S
    Bresalier, RS
    Howell, SB
    Boland, CR
    [J]. GASTROENTEROLOGY, 1999, 117 (01) : 123 - 131
  • [9] Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine
    Carethers, JM
    Hawn, MT
    Chauhan, DP
    Luce, MC
    Marra, G
    Koi, M
    Boland, CR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) : 199 - 206
  • [10] Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer
    Carethers, JM
    Smith, EJ
    Behling, CA
    Nguyen, L
    Tajima, A
    Doctolero, RT
    Cabrera, BL
    Goel, M
    Arnold, CA
    Miyai, K
    Boland, CR
    [J]. GASTROENTEROLOGY, 2004, 126 (02) : 394 - 401